Pharm D Solutions Recalls Oxytocin IV Bags Due to Sterility Concerns
Pharm D Solutions is recalling 264 vials of Oxytocin 30 unit in LR 500 mL IV bags nationwide due to a lack of assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an intravenous medication, which poses a significant risk of serious injury or infection.
Plain-English summary
Pharm D Solutions, LLC is voluntarily recalling 264 vials of Oxytocin 30 unit in LR 500 mL 0.06 units/mL IV bags. The recall is being conducted because of a lack of assurance of sterility for the product.
The affected product is identified by NDC 69699-1203-50. The recall covers specific lots with discard dates ranging from June 13, 2018, to November 20, 2018. The product was distributed nationwide.
Healthcare providers and patients should check their inventory for the affected lot numbers and discard by dates. If the product has already been used, individuals should contact their healthcare provider for guidance.
The recalled product
- Product
- Oxytocin 30 unit in LR 500 mL 0.06 units/mL IV,Pharm D Solutions, Houston, Texas --- NDC 69699-1203-50
- Manufacturer
- Pharm D Solutions, LLC
- Category
- Drug — IV Infusion
- Affected units
- 264
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- Lot: 03152018:12 Discard by: 6/13/2018
- 04182018:08 Discard by: 7/17/2018
- 04302018:94 Discard by: 7/29/2018
- 03292018:44 Discard by: 6/26/2018
- 05212018:95 Discard by: 8/19/2018
- 06142018:46 Discard by: 9/12/2018
- 05312018:37 Discard by: 8/29/2018
- 06282018:80 Discard by: 9/26/2018
- 07312018:12 Discard by: 10/29/2018
- 07102018:53 Discard by: 10/8/2018
- 08222018:18 Discard by: 11/20/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 79 recalled by Pharm D Solutions, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 79 products in this recall →Related recalls
Same manufacturer · Pharm D Solutions, LLC
See all →- SeverePharm D Solutions Recalls Sermorelin/GHRP-2 &6 Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Sermorelin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereFDA Recalls Ipamorelin Acetate Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Testosterone Cypionate Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29